Medicine

All Articles

A chatbot alters the thoughts of conspiracy philosophers

.RESEARCH STUDY HIGHLIGHT.14 October 2024.

A research study of over 2,000 individuals shows that ...

How to make cardiology medical trials more broad #.\n\nVilcant, V., Ceron, C., Verma, G., Zeltser, R. &amp Makaryus, A. N. Introduction of under-represented ethnological and nationalities in cardiovascular clinical trials. Cardiovascular System Bronchi Circ. 31, 1263\u00e2 $\" 1268 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nFilbey, L. et cetera. Improving representativeness in trials: a contact us to action coming from the Global Cardiovascular Medical Trialists Online Forum. Eur. Center J. 44, 921\u00e2 $\" 930 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nJin, X. et cetera. Women\u00e2 $ s involvement in cardiovascular clinical trials coming from 2010 to 2017. Blood circulation 141, 540\u00e2 $\" 548 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nCholesterol Therapy Trialists\u00e2 $ Partnership Efficacy and safety of statin therapy in more mature individuals: a meta-analysis of private participant records from 28 randomised controlled trials. Lancet 393, 407\u00e2 $\" 415 (2019 ). Au, M. et cetera. A systematic assessment of sex-specific coverage in cardiac arrest clinical tests: trial circulation and end results. J. Am. Coll. Cardiol. Adv. 1, 100079 (2022 ).\nGoogle.com Scholar\u00c2.\nWei, S. et al. Factors linked with racial and cultural diversity amongst cardiac arrest test participants: an organized bibliometric evaluation. Circ. Soul Fail. 15, e008685 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nTahhan, A. S. et cetera. Application of much older individuals, ladies, as well as racial\/ethnic minority groups in present-day intense coronary disorder professional trials: a step-by-step customer review. JAMA Cardiol. 5, 714\u00e2 $\" 722 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nCherubini, A. et cetera. The chronic exclusion of much older patients as a result of on-going professional tests relating to heart failure. Arch. Trainee. Medication. 171, 550\u00e2 $\" 556 (2011 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nMichos, E. D. &amp Van Spall, H. G. C. Improving portrayal and diversity in cardio medical trial populaces. Nat. Rev. Cardiol. 18, 537\u00e2 $\" 538 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNational Academies of Sciences, Design, and also Medication. Improving Representation in Professional Tests as well as Analysis: Building Research Study Equity for Women and also Underrepresented Groups (eds Bibbins-Domingo, K. &amp Helman, A.) (National Academies Bunch, 2022). Packer, M. et cetera. Cardiovascular and also kidney end results along with empagliflozin in cardiac arrest. N. Engl. J. Medication. 383, 1413\u00e2 $\" 1424 (2020 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nZannad, F. et cetera. SGLT2 preventions in clients along with heart failure with decreased ejection fraction: a meta-analysis of the EMPEROR-Reduced and also DAPA-HF trials. Lancet 396, 819\u00e2 $\" 829 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nLam, C. S. P. et al. Regional and indigenous impacts on the reaction to empagliflozin in clients along with cardiac arrest and a minimized ejection fraction: the EMPEROR-Reduced trial. Eur. Heart J. 42, 4442\u00e2 $\" 4451 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nRathore, S. S., Wang, Y. &amp Krumholz, H. M. Sex-based differences in the result of digoxin for the therapy of cardiac arrest. N. Engl. J. Med. 347, 1403\u00e2 $\" 1411 (2002 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nMihan, A., Pandey, A. &amp Vehicle Spall, H. G. C. Alleviating the danger of expert system prejudice in cardio treatment. Lancet Digit. Wellness https:\/\/doi.org\/10.1016\/S2589-7500( 24 )00155-9 (2024 ). Bodicoat, D. H. et al. Advertising inclusion in professional trials\u00e2 $\" a quick review of the literature and referrals for action. Trials 22, 880 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nGoldberg, E. M. et al. Utilizing social media for scientific research study: recommendations and instances from the Brown-Lifespan Facility for Digital Health And Wellness. J. Med. Web Res. 24, e35804 (2022 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nMihan, A. &amp Van Spall, H. G. C. Interventions to enhance digital health and wellness equity in cardio care. Nat. Med. 30, 628\u00e2 $\" 630 (2024 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nFultinavi\u00c4 i\u00c5\" t\u00c4 --, U. artificial intelligence perks in individual identification and scientific test recruitment has challenges visible. Scientific Trials Sector https:\/\/www.clinicaltrialsarena.com\/features\/ai-clinical-trial-recruitment\/ (2022 ). Grover, N. &amp Coulter, M. Insight: major pharma bets on AI to speed up medical trials. Reuters https:\/\/www.reuters.com\/technology\/big-pharma-bets-ai-speed-up-clinical-trials-2023-09-22\/ (2023 ). Kretschmer, M., Kretschmer, T., Peukert, A. &amp Peukert, C. The dangers of risk-based AI guideline: taking obligation seriously. SSRN https:\/\/doi.org\/10.2139\/ssrn.4622405 (2023 ). Strumberger, S. EU AI Action: the most up to date updates on the world\u00e2 $ s initially comprehensive AI policy rules. Thomson Reuters https:\/\/legalsolutions.thomsonreuters.co.uk\/blog\/2023\/12\/12\/ai-act-the-worlds-first-comprehensive-laws-to-regulate-ai\/

:~:text=In%20April%202021%2C%20the%20European,mean%20more%20or%20less%20regulation (2024 ). Ali, M. ...

To overcome antimicrobial resistance in Africa, develop regional ability

.Rises in antimicrobial resistance around the globe are actually probably to reach African nations t...

Lessons coming from an unfavorable gene treatment trial for Duchenne muscular dystrophy

.Nature Medicine, Posted online: 09 Oct 2024 doi:10.1038/ s41591-024-03316-9Delandistrogene moxeparv...

People with cardiac front-runners demand multidisciplinary treatment

.Attributes Medicine, Posted online: 09 Oct 2024 doi:10.1038/ s41591-024-03296-wEchocardiographic te...

AAV genetics therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial

.Test oversightThis trial was performed in accordance with the stipulations of the Declaration of He...

Computational brain versions map range inserted in getting older and also alzheimer's disease

.Publisheru00e2 $ s note Springer Attribute stays neutral when it come to managerial insurance claim...

Lassa vaccines to spare lives, extra economies and also assist in astronomical readiness

.Publisheru00e2 $ s note Springer Attributes continues to be neutral for managerial insurance claims...

Putting children\u00e2 $ s protection at the soul of physical violence analysis

.We thank our associates that are actually researchers, plan implementors, social workers, plan manu...

Author Adjustment: MDMA-assisted therapy for modest to intense PTSD: a randomized, placebo-controlled phase 3 trial

.A checklist of participants and also their associations shows up in the Supplementary Information.N...